3. Segment Information and Concentrations

3 Months Ended

Sep. 30, 2016

Segment Reporting [Abstract]

Segment Information and Concentrations

The Company views its operations as three segments:the manufacture and marketing of standard benchtop laboratory equipment including the balances and scales by its Torbal Scales Division for research in university, hospital and industrial laboratories sold primarily through laboratory equipment distributors and on a direct basis (“Benchtop Laboratory Equipment”), the manufacture and marketing of custom-made catalyst research instruments for universities, government laboratories, and chemical and petrochemical companies sold on a direct basis (“Catalyst Research Instruments”) and the design and marketing of bioprocessing systems for laboratory research in the biotechnology industry sold directly to customers and through distributors and related royalty income (“Bioprocessing Systems”).

Segment information is reported as follows:

	Benchtop Laboratory Equipment	Catalyst Research Instruments	Bioprocessing Systems	Corporate and Other	Consolidated
Three months ended September 30, 2016:
Revenues	$ 1,456,800	$77,500	$ 24,800	$ -	$ 1,559,100
Foreign Sales	561,200	4,800	-	-	566,000
Income (Loss) from Operations	101,400	(141,700)	(34,700)		(75,000)
Assets	4,034,400	2,286,700	428,100	692,200	7,441,400
Long-Lived Asset Expenditures	8,400	-	-	-	8,400
Depreciation and Amortization	76,700	6,600	12,400	-	95,700

	Benchtop Laboratory Equipment	Catalyst Research Instruments	Bioprocessing Systems	Corporate and Other	Consolidated
Three months ended September 30, 2015:
Revenues	$1,263,000	$153,000	$28,500	$-	$1,444,500
Foreign Sales	599,000	7,800	-	-	606,800
Income (Loss) from Operations	54,700	(82,000)	(30,100)	(8,100)	(65,500)
Assets	4,056,400	1,613,200	730,700	564,400	6,964,700
Long-Lived Asset Expenditures	6,500	-	-	-	6,500
Depreciation and Amortization	73,800	6,900	24,500	-	105,200

Approximately 49% and 47% of net sales of benchtop laboratory equipment for the three month periods ended September 30, 2016 and 2015, respectively, were derived from the Company’s main product, the Vortex-Genie 2® mixer, excluding accessories. Approximately 26% and 21% of total benchtop laboratory equipment sales were derived from the Torbal Scales Division for the three months ended September 30, 2016 and 2015, respectively.

For the three months ended September 30, 2016, and 2015, respectively, two customers accounted in the aggregate for approximately 16% and 13% of net sales of the Benchtop Laboratory Equipment Operations (15% and 11% of the Company’s total revenues). Sales of catalyst research instruments generally comprise a few very large orders averaging at least $100,000 per order to a limited number of customers, who differ from order to order. Sales to one customer (who differed from period-to-period) during the three months ended September 30, 2016 and 2015, accounted respectively, for approximately 57% and 76% of the Catalyst Research Instrument Operations’ revenues and 3% and 8% of the Company’s total revenues, respectively.